Venture Round - Autobahn Therapeutics
Investment Firm
Overview
Autobahn Therapeutics is a developer of regenerative medicines to restore hope for people affected by CNS disorders.
Announced Date
Sep 08, 2022
Funding Type
Series Unknown
Highlights
Location
United States, North America
Social
Investor Lead
N/A
Participant Investors
8
Round Details and Background
Autobahn Therapeutics raised $32700000 on 2022-09-08 in Venture Round
Autobahn Therapeutics is a developer of regenerative medicines to restore hope for people affected by CNS disorders.
Company Funding History
3
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Jun 11, 2020 |  Series B - Autobahn Therapeutics | 10 | - | 76.0M |
| Sep 08, 2022 | Venture Round - Autobahn Therapeutics | 11 | - | 32.7M |
| Jul 24, 2024 | Series C - Autobahn Therapeutics | 15 | - | 100.0M |